SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

Market sentiment remains highly divided as investors weigh rising bond yields and geopolitical tensions against persistent optimism surrounding AI-related growth and major index performance. Traders are actively debating whether recent volatility indicates a sustained reversal or if the market is primed for a continuation of its current uptrend through dip-buying activity.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

Market participants are actively debating the sustainability of current highs, with intense focus on the AI sector's massive capital expenditure and the broader implications of rising bond yields. Community discussion is dominated by a divide between those betting on continued momentum driven by corporate earnings and those positioning for potential volatility around options expiration.

Figma, Inc. is an AI-powered digital design and product development platform. The firm offers tools for teams to collaborate on the entire lifecycle of software creation. Its products include FigJam, Figma Slides, Figma Design, Figma Draw, Dev Mode, Figma Sites, Figma Buzz and Figma Make. The company was founded by Dylan Joseph Field and Evan Darrow Wallace in 2012 and is headquartered in San Francisco, CA.

Figma Inc. - Ordinary Shares - Class A

Figma

Figma is trending following a strong quarterly earnings report featuring revenue growth that beat analyst expectations and raised full-year guidance, fueled by accelerating enterprise adoption of its AI-powered features. Community sentiment is heavily focused on a potential short squeeze, with investors highlighting significant short interest and arguing that the companys strong net dollar retention and essential role in design workflows prove its long-term value despite broader market concerns about AI competition.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Direxion Daily Semiconductor Bear 3X Shares is trending as traders debate the sustainability of the semiconductor rally, with many expressing deep frustration over the asset's volatility decay and the aggressive market momentum driving chip valuations to historic highs. The conversation is dominated by intense disagreement between retail bears expecting a market correction tied to geopolitical tensions and macroeconomic data, and bulls who remain convinced that AI-related capital expenditure will continue to fuel industry growth.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending due to renewed optimism regarding chip sales in China, fueling investor anticipation as the company nears its upcoming earnings report. The community remains deeply divided, with bulls pointing to the stock's dominant AI market position and potential for continued growth, while bears express concerns over its massive market capitalization and the sustainability of current AI-driven valuations.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is experiencing heightened investor interest ahead of a highly anticipated plenary presentation at the AUA annual meeting, where the company will share updated, extended follow-up data from its pivotal Phase 3 trial. The community is actively discussing the potential for this data to solidify the drug's role as a practice-changing standard of care, with sentiment bolstered by strong institutional backing and speculation regarding the asset's commercial value in the large localized prostate cancer market.

Gemini Space Station, Inc. is a holding company, which offers a mobile and web based crypto asset exchange platform, proprietary wallet infrastructure and custody solutions, over-the-counter trading solutions tailored to institutions and professionals, a digital art auction platform, a proprietary United States dollar backed stablecoin, and a credit card product that offers crypto asset rewards on customer purchases. The company was founded by Tyler Winklevoss and Cameron Winklevoss in 2014 and is headquartered in New York, NY.

Gemini Space Station Inc. - Ordinary Shares- Class A

Gemini Space Station

Gemini Space Station is rallying following a $100 million strategic investment from the Winklevoss Capital Fund, paired with better-than-expected quarterly results. The community is actively discussing potential for a short squeeze given high short interest, while some remain cautious due to ongoing legal scrutiny and the stock's significant decline since its IPO.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. (UAMY) is facing increased volatility as investors react to a disappointing first-quarter earnings report, which highlighted significant net losses and delayed production timelines at its Montana smelter. Despite these operational setbacks, the community remains deeply divided, with many long-term shareholders advocating to 'buy the fear' based on strong government grant milestones, domestic supply chain importance, and the significant future value of its tungsten assets.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending as the stock experiences high volatility following a notable earnings beat and renewed investor interest in its role as a key supplier for aerospace and defense sectors, including collaborations with major entities like SpaceX and Anduril. The community is actively debating the impact of the company's recent capital raises and insider selling, with bullish traders highlighting the stock's short-squeeze potential while bearish voices caution about ongoing dilution and the company's path to profitability.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan D. Green on March 5, 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is trending as investors debate whether recent price weakness represents a deep-value opportunity supported by share buybacks, strong cash flow, and institutional accumulation, or a continued downtrend fueled by competitive pressures and earnings misses. The community is actively weighing the potential for a rebound driven by these aggressive capital allocation strategies against concerns over stagnant growth and the threat of autonomous vehicle disruption.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS focus on actual data / facts. 
26 months after enrollment completed, 49 / 50 patients Remain Alive  
🙏 
Very Ill, Transplant Ineligible Post secondary salvage, AML Cr2 setting where the largest US REGAL clinician is on record saying &#39;you will not see survival past 12 months&#39;. 
 
- 3 Dr&#39;s Treating actual Patients are on record stating MOS for patients onBAT is &#39;dismal, not durable&#39;, &#39;extremely poor - 5-7 months&#39;. 
 
MOS and IR data from the actual Interim Analysis - was UNBLINDED. 
Industry Players accumulating Know. 
Most of the 49 or 50 REGAL Phase 3 Patients, who remain continue receive GPS Immunotherapy. 
 
- after being asked precisely how long do control patients survive in his clinical practice experience using BAT. 
&quot; Median OS is just 7 months, 6-8 months. &quot; Using Aza + VEN 
Aza+VEN BAT recently Failed Large Phase 3 Trials conducted by $ABBV, including 2 Ph 3 Fails for AML Remission Maintenance.  
VIALE-M FAILED - VIALE-T FAILED - VERONA Failed 
 
*source full transcript

Frog Prince

William

Jeremy Dworkin

Tony M

Anne Ewing

Jon brand

CMSP

StockTwits Web

SELLAS Life Sciences Group Inc

Abbvie Inc

 focus on actual data / facts. 
26 months after enrollment completed, 49 / 50 patients Remain Alive  
🙏 
Very Ill, Transplant Ineligible Post secondary salvage, AML Cr2 setting where the largest US REGAL clinician is on record saying 'you will not see survival past 12 months'. 
 
- 3 Dr's Treating actual Patients are on record stating MOS for patients onBAT is 'dismal, not durable', 'extremely poor - 5-7 months'. 
 
MOS and IR data from the actual Interim Analysis - was UNBLINDED. 
Industry Players accumulating Know. 
Most of the 49 or 50 REGAL Phase 3 Patients, who remain continue receive GPS Immunotherapy. 
 
- after being asked precisely how long do control patients survive in his clinical practice experience using BAT. 
" Median OS is just 7 months, 6-8 months. " Using Aza + VEN 
Aza+VEN BAT recently Failed Large Phase 3 Trials conducted by 

, including 2 Ph 3 Fails for AML Remission Maintenance.  
VIALE-M FAILED - VIALE-T FAILED - VERONA Failed 
 
*source full transcript